Salarius Pharmaceuticals (SLRX) - Uzoq muddatli qarzning kapitalga nisbati

Salarius Pharmaceuticals (SLRX) korporativ emblemasi va logotipi

Salarius Pharmaceuticals (SLRX) terapiya vositalarining yetishmasligi sababli talab juda yuqori bo'lgan bolalar o'smalari bilan kurashish uchun epigenetika nishasiga kirib bormoqda. Biznes barcha ishlanmalar va sintezni tashqi pudratchilar orqali autsorsing qilishga tayanadi va GURU.Markets platformasidagi separate_debt_long_eq ko'rsatkichi 0.00 darajasida turibdi. Ushbu grafikdagi chiziqli narx harakati kompaniyaga tegishli bozor tendentsiyasini aks ettiradi, uning ishlanmalari patentlar va kamyob dori vositasi maqomi bilan himoyalangan bo'lib, bu esa kirish uchun ulkan moliyaviy to'siqni yaratadi.

Salarius - SLRX Uzoq muddatli qarzning kapitalga nisbati (davr: 04.07.2022 - 08.01.2026)

Salarius Pharmaceuticals kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Salarius Pharmaceuticals Inc|SLRX - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi Salarius Pharmaceuticals, Inc.|SLRX - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga xususiy kapital Salarius Pharmaceuticals|SLRX - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati salariuspharma.com|SLRX - Kompaniyaning umumiy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati Salarius Pharmaceuticals|SLRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati salariuspharma.com|SLRX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Salarius Pharmaceuticals, Inc.|SLRX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Salarius Pharmaceuticals|Tezkor likvidlik koeffitsiyenti salariuspharma.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
SLRX - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:Salarius Pharmaceuticals Inc - SLRX
salariuspharma.com original mahsuloti

Investorlar biznesning moliyaviy barqarorligini uning qarz kapitaliga bog'liqlik darajasi orqali baholaydilar. Ushbu ko'rsatkich muddati bir yildan ortiq bo'lgan kreditlar hajmini o'z kapitali miqdori bilan solishtiradi. Tijoratdan oldingi biotexnologiya kompaniyasi Salarius Pharmaceuticals (SLRX) uchun daromadning yo'qligi qarzni kritik xavfga aylantiradi. Tadqiqot va ishlanmalar (R&D) xarajatlarining chiziqli o'sishi bilan birga yuqori kredit yuklamasi bankrotlikka olib kelishi mumkin. Uzoq muddatli qarzning kapitalga nisbati dinamikasini tahlil qilish orqali kompaniyaning xavfsizlik zaxirasini aniqlash mumkin.

Muhim raqobatchilar

Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|CGON: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Bicara Therapeutics Inc (BCAX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PSNL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Erasca Oncology (ERAS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Delcath Systems, Inc.|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AURA (Aura Biosciences)|CADL (candeltx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ARAY (Accuray Inc.)|SLS - Uzoq muddatli qarzning o'z kapitaliga nisbati|ACTU: Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR - Uzoq muddatli qarzning kapitalga nisbati|tuhurabio.com (HURA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protara Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|FATE (Fate Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Aadi Bio WHWK|Uzoq muddatli qarzning o'z kapitaliga nisbati TScan Therapeutics (TCRX)|Uzoq muddatli qarzdorlikning kapitalga nisbati championsoncology.com|Uzoq muddatli qarzning kapitalga nisbati XBIT (XBiotech)|Uzoq muddatli qarzning kapitalga nisbati CEL-SCI Corp. CVM|OSTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|RADX: Uzoq muddatli qarzning o'z kapitaliga nisbati|ARTV: Uzoq muddatli qarzning kapitalga nisbati|Adlai Nortye (ANL) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Veru|TPST: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XLO|Uzoq muddatli qarzdorlikning kapitalga nisbati renovarobio.com|Mural Oncology - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Kairos Pharma Limited KAPA|OKUR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati CytoMed Therapeutics GDTC|CRIS (curis.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Apollomics - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Tharimmune, Inc.|Advanced Biomed Corp - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GNPX|CLDI (calidibio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SBFM (Sunshine Biopharma)|Uzoq muddatli qarzning kapitalga nisbati Xenetic Biosciences Inc. XBIO|PPBT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AONC (American Oncology Network)|BeiGene (BGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Checkpoint Therapeutics Inc.|ELEV (Elevation Oncology, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati iCAD Corp|Uzoq muddatli qarzning kapitalga nisbati IKNA|Uzoq muddatli qarzning o'z kapitaliga nisbati notablelabs.com NTBL|Uzoq muddatli qarzning kapitalga nisbati VIRX (Viracta Therapeutics, Inc.)|MorphoSys Inc (MOR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NAYA: Uzoq muddatli qarzning o'z kapitaliga nisbati|AAPGV - Uzoq muddatli qarzning kapitalga nisbati